HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perez-Reyes, E. Search for Related Content PubMed PubMed Citation Articles by Perez-Reyes, E.

Paradoxical Role of T-type Calcium Channels in Coronary Smooth Muscle

Department of Pharmacology, P.O. Box 800735, 1300 Jefferson Park Avenue, Charlottesville, VA 22908-0735

SUMMARY

Of the ten mammalian voltage-gated calcium channels (VGCCs), those belonging to the L-type family have been best studied for the development of useful therapeutics for hypertension. Other studies on drugs that target the T-type family of VGCCs suggest that T-type channels might also be relevant to clinically directed modulation of hypertension; however, the selectivity of one such drug (i.e., mibefradil) has been called into question. CacnaH1 encodes Ca_v3.2, one of the three T-type channels. Recently, Cacna1H^-/- mice were developed to ascertain the normal roles of T-type channels. Ca_v3.2-null mice possess continually constricted arterioles in the heart. The smooth muscle and arterioles from isolated knockout mice are able to contract normally in vitro; however, in the presence of acetylcholine (ACh) or other relaxing agents, the mutant vasculature is unable to relax to the same degree as does wild-type vasculature. Similarly, blocking wild-type T-type channels prevents ACh-mediated relaxation. These results suggest an important role of T-type channels in normal cardiovascular function. But is hope for a specific and useful T-type channel–targeted drug premature?

This article has been cited by other articles:

				A. M. Blanks, Z.-H. Zhao, A. Shmygol, G. Bru-Mercier, S. Astle, and S. Thornton Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium J. Physiol., June 15, 2007; 581(3): 915 - 926. [Abstract] [Full Text] [PDF]

				S. Moosmang, N. Haider, B. Bruderl, A. Welling, and F. Hofmann Antihypertensive Effects of the Putative T-Type Calcium Channel Antagonist Mibefradil Are Mediated by the L-Type Calcium Channel Cav1.2 Circ. Res., January 6, 2006; 98(1): 105 - 110. [Abstract] [Full Text] [PDF]